Cargando…

Beyond Ejection Fraction: Novel Clinical Approaches Towards Sudden Cardiac Death Risk Stratification in Patients with Dilated Cardiomyopathy

Implantable Cardioverter-Defibrillator (ICD) therapy is indicated for patients at risk for sudden cardiac death due to ventricular tachyarrhythmia. The most commonly used risk stratification algorithms use Left Ventricular Ejection Fraction (LVEF) to determine which patients qualify for ICD therapy,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pour-Ghaz, Issa, Heckle, Mark, Ifedili, Ikechukwu, Kayali, Sharif, Nance, Christopher, Kabra, Rajesh, Jha, Sunil K., Jefferies, John L., Levine, Yehoshua C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413734/ https://www.ncbi.nlm.nih.gov/pubmed/34348632 http://dx.doi.org/10.2174/1573403X17666210804125939

Ejemplares similares

Ablation Therapy for Persistent Atrial Fibrillation
por: Ifedili, Ikechukwu, et al.
Publicado: (2022)

PO-679-06 SAME DAY DISCHARGE AND 30 DAY READMISSION AFTER ATRIAL FIBRILLATION ABLATION BEFORE AND DURING THE COVID-19 PANDEMIC IN A TWO HOSPITAL HEALTHCARE SYSTEM
por: Bath, Anandbir, et al.
Publicado: (2022)

Diagnosis and management of inadvertently placed pacemaker lead in the left ventricle following sinus venosus atrial septal defect repair surgery
por: Teshome, Meron, et al.
Publicado: (2020)

Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
por: Akhtar, M., et al.
Publicado: (2019)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

A Case of Low Ejection Fraction Unrelated to Anthracycline Therapy: Chemo Tells a Fib
por: DeCarr, Kimberly, et al.
Publicado: (2023)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

Emerging role of genetic analysis for stratification of sudden cardiac death risk in dilated cardiomyopathy: An illustrative case
por: Yao, Jessica Victoria, et al.
Publicado: (2020)

Impact of Pre-existing Kidney Dysfunction on Outcomes Following  Transcatheter Aortic Valve Replacement
por: Ifedili, Ikechukwu A., et al.
Publicado: (2017)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Hypertrophic cardiomyopathy: Sudden cardiac death risk stratification in adults
por: Jordà, Paloma, et al.
Publicado: (2018)

Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy
por: Klüser, L., et al.
Publicado: (2016)

Dilated Cardiomyopathy: A Comprehensive Approach to Diagnosis and Risk Stratification
por: Ferreira, André, et al.
Publicado: (2023)

Outcomes of Spironolactone Withdrawal in Dilated Cardiomyopathy With Improved Ejection Fraction
por: Chen, Yanjia, et al.
Publicado: (2021)

The Roles of Coronary Computed Tomography Angiography in Characterizing Coronary Plaque: Screening, Treatment, and Prevention
por: Pour-Ghaz, Issa, et al.
Publicado: (2023)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Levamisole-induced Vasculitis in a Hepatitis C Patient: A General Medicine Ward Perspective on Diagnosis and Management
por: Latif, Zara, et al.
Publicado: (2019)

New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
por: Pio Loco detto Gava, Carola, et al.
Publicado: (2023)

Are We Getting Closer to Risk Stratification in Left Ventricular Noncompaction Cardiomyopathy?
por: Jefferies, John L.
Publicado: (2018)

Plasma microrna expression profile for reduced ejection fraction in dilated cardiomyopathy
por: Calderon-Dominguez, Maria, et al.
Publicado: (2021)

Novel Device Therapies for Heart Failure
por: Alkhatib, Deya, et al.
Publicado: (2023)

Dilated Cardiomyopathy in a Child with COVID-19
por: Kishore, Rashmi, et al.
Publicado: (2020)

Risk Stratification in Idiopathic Dilated Cardiomyopathy Patients Using Cardiovascular Coupling Analysis
por: Rodriguez, Javier, et al.
Publicado: (2019)

Dilated Cardiomyopathy With Mid‐Range Ejection Fraction at Diagnosis: Characterization and Natural History
por: Gentile, Piero, et al.
Publicado: (2019)

The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Sudden Cardiac Arrest in the Postpartum Period Due to Long QT Syndrome and Dilated Cardiomyopathy
por: Patterson, Daniel R., et al.
Publicado: (2023)

Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registry
por: Henkens, Michiel T.H.M., et al.
Publicado: (2022)

Identification of heart failure with preserved ejection fraction helps risk stratification for hypertrophic cardiomyopathy
por: Liu, Jie, et al.
Publicado: (2022)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Sudden cardiac death diagnosed with dilated cardiomyopathy in a Kuwaiti family: a case report
por: Bulbanat, Bassam, et al.
Publicado: (2014)

Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach
por: Hammersley, Daniel J., et al.
Publicado: (2020)

An ABCC9 Missense Variant Is Associated with Sudden Cardiac Death and Dilated Cardiomyopathy in Juvenile Dogs
por: Furrow, Eva, et al.
Publicado: (2023)

Measurement of multiple cytokines for discrimination and risk stratification in patients with Chagas’ disease and idiopathic dilated cardiomyopathy
por: Wang, Yong, et al.
Publicado: (2021)

Well-Known and Novel Serum Biomarkers for Risk Stratification of Patients with Non-ischemic Dilated Cardiomyopathy
por: Anghel, Larisa, et al.
Publicado: (2021)

The decisive role of cardiovascular MRI delayed hyperenhancement (DHE) pattern for risk stratification for dilated cardiomyopathy
por: Venero, Jose V, et al.
Publicado: (2009)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Left ventricular hypertrophy, dilatation and ejection fractions predict ventricular tachycardia in amyloid transthyretin cardiomyopathy
por: Knoll, K, et al.
Publicado: (2023)

Characteristics of the right ventricle in left ventricular noncompaction with reduced ejection fraction in the light of dilated cardiomyopathy
por: Gregor, Zsófia, et al.
Publicado: (2023)

Native T1 high region and left ventricular ejection fraction recovery in patients with dilated cardiomyopathy
por: Yazaki, Mayu, et al.
Publicado: (2023)

Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy
por: Ishihara, Kakeru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_76v5bh1iq58nkmdqbu9sbi2epc